Rothschild & Co Advised on IndiaRF Stake Sale in Synthimed Labs
Rothschild & Co SCA has been appointed as the financial advisor to India Resurgence Fund (IndiaRF), a joint venture between the Piramal Group and Bain Capital, for the sale of a portion of its stake in Synthimed Labs Pvt Ltd (SLPL). The appointment follows IndiaRF’s decision to initiate the stake‑sale process, with the goal of identifying potential buyers for the portfolio company.
The engagement underscores Rothschild & Co’s expertise in merger and acquisition advisory, particularly in cross‑border transactions. As the advisory partner, Rothschild & Co will leverage its extensive network and market knowledge to source qualified buyers and negotiate terms that align with IndiaRF’s strategic objectives.
The transaction reflects ongoing activity in the Indian healthcare sector, where private equity and strategic investors are increasingly active. Rothschild & Co’s role will be crucial in navigating regulatory requirements, structuring the sale, and ensuring optimal valuation for IndiaRF.